[{"name":"疗效评价","count":3484,"id":1},{"name":"临床研究","count":2958,"id":2},{"name":"医院药学","count":1357,"id":3},{"name":"中医中药","count":987,"id":4},{"name":"论著","count":872,"id":5},{"name":"综述","count":676,"id":6},{"name":"实验研究","count":411,"id":7},{"name":"护理研究","count":251,"id":8},{"name":"安全评价","count":203,"id":9},{"name":"本期独家策划","count":200,"id":10},{"name":"药物评价","count":160,"id":11},{"name":"观察","count":147,"id":12},{"name":"Exclusive","count":124,"id":13},{"name":"专栏","count":107,"id":14},{"name":"Column","count":95,"id":15},{"name":"学术聚焦","count":90,"id":16},{"name":"资讯","count":85,"id":17},{"name":"环球视点","count":77,"id":18},{"name":"不良反应","count":73,"id":19},{"name":"Academic Horizon","count":72,"id":20},{"name":"药事管理","count":70,"id":21},{"name":"Observation","count":69,"id":22},{"name":"独家策划","count":55,"id":23},{"name":"本期关注","count":51,"id":24},{"name":"案例分析","count":51,"id":25},{"name":"制药研究","count":49,"id":26},{"name":"循证药学","count":43,"id":27},{"name":"新药速递","count":43,"id":28},{"name":"封面人物","count":41,"id":29},{"name":"关注","count":40,"id":30},{"name":"时评","count":38,"id":31},{"name":"学术视野","count":37,"id":32},{"name":"院士讲坛","count":34,"id":33},{"name":"会议追踪","count":31,"id":34},{"name":"药品监管论坛","count":31,"id":35},{"name":"News","count":27,"id":36},{"name":"学术论坛","count":26,"id":37},{"name":"封面","count":25,"id":38},{"name":"JCPD·CSCO:中国肿瘤临床专版","count":24,"id":39},{"name":"飞絮","count":24,"id":40},{"name":"名刊精点","count":23,"id":41},{"name":"数据","count":21,"id":42},{"name":"肿瘤专题","count":21,"id":43},{"name":"茶座","count":21,"id":44},{"name":"FDA华人系列","count":20,"id":45},{"name":"JCPD·CSCO中国临床肿瘤专版","count":19,"id":46},{"name":"JCPD·CSCO临床肿瘤专版","count":19,"id":47},{"name":"SPECIAL REPORT","count":19,"id":48},{"name":"制药技术","count":19,"id":49},{"name":"心血管专题","count":19,"id":50},{"name":"上市后再评价","count":18,"id":51},{"name":"前沿视窗","count":18,"id":52},{"name":"卷首语","count":18,"id":53},{"name":"时政直击","count":18,"id":54},{"name":"药人飞絮","count":18,"id":55},{"name":"药物鉴定","count":18,"id":56},{"name":"Exclusive: Pantheon of Clinical Trial in China","count":17,"id":57},{"name":"心血管疾病治疗专题","count":17,"id":58},{"name":"呼吸专题","count":16,"id":59},{"name":"药事沙龙","count":16,"id":60},{"name":"合理用药","count":15,"id":61},{"name":"肿瘤治疗","count":14,"id":62},{"name":"论坛","count":14,"id":63},{"name":"Focus","count":13,"id":64},{"name":"主编寄语","count":13,"id":65},{"name":"老年疾病用药专题","count":13,"id":66},{"name":"药物研发","count":13,"id":67},{"name":"信箱","count":12,"id":68},{"name":"前沿","count":12,"id":69},{"name":"生物制药专题","count":12,"id":70},{"name":"神经专题","count":12,"id":71},{"name":"肾脏疾病治疗专题","count":12,"id":72},{"name":"读编往来","count":12,"id":73},{"name":"靶向肿瘤","count":12,"id":74},{"name":"Academic Periscope:Cancer Chemotherapy in 2007","count":11,"id":75},{"name":"Exclusive:Survey on Clinical Trial Bases in China","count":11,"id":76},{"name":"JCPD·CSCO","count":11,"id":77},{"name":"JCPD·CSCO:盛事","count":11,"id":78},{"name":"学术经纬","count":11,"id":79},{"name":"学术视野:2007年肿瘤化疗进展","count":11,"id":80},{"name":"抗生素合理应用&处方管理","count":11,"id":81},{"name":"糖尿病专题","count":11,"id":82},{"name":"调脂","count":11,"id":83},{"name":"院士面对面","count":11,"id":84},{"name":"American-Chinese Elites in FDA","count":10,"id":85},{"name":"Focus: 2007 CSCO","count":10,"id":86},{"name":"Insight","count":10,"id":87},{"name":"临床研究点评","count":10,"id":88},{"name":"学术视野:聚焦心血管","count":10,"id":89},{"name":"抗感染专题","count":10,"id":90},{"name":"肿瘤治疗专题","count":10,"id":91},{"name":"药物研究","count":10,"id":92},{"name":"血栓专题","count":10,"id":93},{"name":"American-Chinese Elite in FDA","count":9,"id":94},{"name":"Exclusive:Kaleidoscope--Chinese Expression","count":9,"id":95},{"name":"JCPD·CSCO Clinical Oncology","count":9,"id":96},{"name":"WATCH","count":9,"id":97},{"name":"一家之言","count":9,"id":98},{"name":"中药专题","count":9,"id":99},{"name":"临床病例解析","count":9,"id":100},{"name":"儿科疾病治疗","count":9,"id":101},{"name":"医院故事","count":9,"id":102},{"name":"妇产科","count":9,"id":103},{"name":"妇产科专题","count":9,"id":104},{"name":"妊娠期高血压疾病?专题","count":9,"id":105},{"name":"封面·寄语","count":9,"id":106},{"name":"抗真菌治疗","count":9,"id":107},{"name":"推广","count":9,"id":108},{"name":"睡眠疾病","count":9,"id":109},{"name":"聚焦","count":9,"id":110},{"name":"肝病治疗专题","count":9,"id":111},{"name":"肺动脉高压药物治疗","count":9,"id":112},{"name":"药物故事","count":9,"id":113},{"name":"Forum on Drug Administration and Surveillance","count":8,"id":114},{"name":"Reevaluation of launched drugs","count":8,"id":115},{"name":"医院管理","count":8,"id":116},{"name":"学术视野:消化疾病专题","count":8,"id":117},{"name":"学术视野:药物流行病学专题","count":8,"id":118},{"name":"心血管疾病药物治疗","count":8,"id":119},{"name":"抑郁症治疗","count":8,"id":120},{"name":"神经疾病治疗专题","count":8,"id":121},{"name":"耐药与抗菌药","count":8,"id":122},{"name":"药物市场","count":8,"id":123},{"name":"药物经济学","count":8,"id":124},{"name":"Exclusive: Clinical Trial, Select China?","count":7,"id":125},{"name":"Exclusive:Pantheon of Clinical Trial in China","count":7,"id":126},{"name":"JCPD-CSCO肿瘤药物治疗","count":7,"id":127},{"name":"专栏·力量","count":7,"id":128},{"name":"乙肝治疗","count":7,"id":129},{"name":"乳腺癌治疗","count":7,"id":130},{"name":"人物","count":7,"id":131},{"name":"会讯","count":7,"id":132},{"name":"关注国粹","count":7,"id":133},{"name":"学术视野:HRT,又起争议","count":7,"id":134},{"name":"学术视野:抗精神病药物,也需合理应用","count":7,"id":135},{"name":"学术视野:罗格列酮的心血管安全性","count":7,"id":136},{"name":"学术视野:老年心血管病专题","count":7,"id":137},{"name":"封面故事","count":7,"id":138},{"name":"心血管","count":7,"id":139},{"name":"心血管疾病治疗","count":7,"id":140},{"name":"本月特稿","count":7,"id":141},{"name":"本期独家策划 抗生素南方版图","count":7,"id":142},{"name":"消化疾病治疗专题","count":7,"id":143},{"name":"生物制药","count":7,"id":144},{"name":"社区医疗","count":7,"id":145},{"name":"聚集","count":7,"id":146},{"name":"Academic Horizon: Dispute over HRT again","count":6,"id":147},{"name":"Academic Horizon:Digestive Disease","count":6,"id":148},{"name":"Academic Periscope:Cardiovascular Safety of Rsigliazone","count":6,"id":149},{"name":"Data","count":6,"id":150},{"name":"Focus: JCPD·CSCO","count":6,"id":151},{"name":"Focus:JCPD·CSCO","count":6,"id":152},{"name":"JCPO CSCO临床肿瘤专版","count":6,"id":153},{"name":"TOPIC","count":6,"id":154},{"name":"内分泌疾病治疗专题","count":6,"id":155},{"name":"前 沿","count":6,"id":156},{"name":"外包与服务","count":6,"id":157},{"name":"学术争议","count":6,"id":158},{"name":"学术视野:2008ASCO精彩荟萃","count":6,"id":159},{"name":"学术视野:肝硬化及其并发症","count":6,"id":160},{"name":"学术视野:血糖控制与临床结局","count":6,"id":161},{"name":"急性冠脉综合征","count":6,"id":162},{"name":"本期独家策划:医药转型期创新型企业的崛起","count":6,"id":163},{"name":"消化专版·炎症性肠病","count":6,"id":164},{"name":"消化专版·酒精性肝病","count":6,"id":165},{"name":"现代管理","count":6,"id":166},{"name":"糖尿病药物治疗","count":6,"id":167},{"name":"细菌耐药监测 & 真菌治疗","count":6,"id":168},{"name":"肺癌","count":6,"id":169},{"name":"药学研究","count":6,"id":170},{"name":"葛根素治疗心脑血管疾病","count":6,"id":171},{"name":"血液治疗专题","count":6,"id":172},{"name":"镇痛治疗","count":6,"id":173},{"name":"风湿免疫","count":6,"id":174},{"name":"麻醉镇痛","count":6,"id":175},{"name":"\"防止滥用抗生素\"专题","count":5,"id":176},{"name":"2008 CSCO年会","count":5,"id":177},{"name":"ANTIBACTERIAL","count":5,"id":178},{"name":"Academic Horizon: Biological Therapy of Cancer","count":5,"id":179},{"name":"CSCO 2008","count":5,"id":180},{"name":"Cover Story","count":5,"id":181},{"name":"FOCUS","count":5,"id":182},{"name":"Profile","count":5,"id":183},{"name":"Review","count":5,"id":184},{"name":"不孕症与宫内病儿药物治疗","count":5,"id":185},{"name":"专栏-力量","count":5,"id":186},{"name":"专栏·范大超","count":5,"id":187},{"name":"个体化药物治疗","count":5,"id":188},{"name":"产业报道","count":5,"id":189},{"name":"儿科专题","count":5,"id":190},{"name":"医疗器械","count":5,"id":191},{"name":"哮喘治疗","count":5,"id":192},{"name":"学术视野:肿瘤生物学治疗","count":5,"id":193},{"name":"学术视野：肺动脉高压的靶向治疗","count":5,"id":194},{"name":"市场解读","count":5,"id":195},{"name":"慢性阻塞性肺疾病专版","count":5,"id":196},{"name":"抗生素专题","count":5,"id":197},{"name":"新药推介","count":5,"id":198},{"name":"新药视窗","count":5,"id":199},{"name":"本期独家策划:药物临床试验完结篇","count":5,"id":200}]
